权威例句
Harmonization of molecular monitoring of CML therapy in EuropeNilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.Translation of the Philadelphia chromosome into therapy for CMLLoss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In VivoMonitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current ...Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CMLDetection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, an...Environmental Life Cycle Assessment of Products. Guide (Part 1) and Backgrounds (Part 2), prepared by CMLDasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fr...Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group